Global, Regional, and National Burden of Mesothelioma 1990-2019 A Systematic Analysis of the Global Burden of Disease Study 2019

被引:3
|
作者
Han, Jonghoon [3 ]
Park, Seoyeon [3 ]
Yon, Dong Keon [4 ,5 ]
Lee, Seung Won [6 ]
Woo, Wongi [1 ]
Dragioti, Elena [7 ,8 ]
Koyanagi, Ai [9 ,10 ,11 ]
Jacob, Louis [9 ,12 ]
Kostev, Karel [13 ]
Radua, Joaquim [14 ]
Lee, Sungsoo [1 ]
Shin, Jae Il [2 ]
Smith, Lee [15 ]
机构
[1] Yonsei Univ, Gangnam Severance Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Yonsei Univ, Dept Pediat, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Seoul, South Korea
[4] Kyung Hee Univ, Med Sci Res Inst, Seoul, South Korea
[5] Kyung Hee Univ, Kyung Hee Univ Med Ctr, Dept Pediat, Coll Med, Seoul, South Korea
[6] Sungkyunkwan Univ, Sch Med, Suwon, South Korea
[7] Linkoping Univ, Pain & Rehabil Ctr, Linkoping, Sweden
[8] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
[9] Parc Sanitari St Joan De Deu, Unidad Invest Desarrollo, St Boi De Llobregat, Spain
[10] Ctr Invest Biomed Red Salud Mental, Barcelona, Spain
[11] Catalan Inst Res & Adv Studies, Barcelona, Spain
[12] Univ Clin Marburg, Marburg, Germany
[13] Univ Versailles St Quentin En Yvelines, Fac Med, Versailles, France
[14] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Ctr Invest Biomed Red Salud Mental, Imatge Trastorns Relacionats Estat Anim Ansietat, Barcelona, Spain
[15] Anglia Ruskin Univ, Ctr Hlth Performance & Wellbeing, Cambridge, England
基金
新加坡国家研究基金会;
关键词
epidemiology; mesothelioma; asbestos; global health; incidence; ASBESTOS; EXPOSURE; DEATHS;
D O I
10.1513/AnnalsATS.202209-802OC
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: Mesothelioma has become a major health burden since World War II because of the use of asbestos. Although many countries have imposed bans on asbestos, there remain significant mortality and morbidity from mesothelioma because of its long latent period and aggressiveness. Also, the use of asbestos is increasing in low-income countries, potentiating risk of mesothelioma in the coming decades. Assessment of the global burden of mesothelioma is required to take proper measures against the disease. Objectives: To assess the burden of mesothelioma from 1990 to 2019 at the global, regional, and national levels and to investigate patterns according to sex, age, sociodemographic index, and risk factors. Methods: The numbers, rates, and age-standardized rates of incidence, death, and disability-adjusted life years (DALYs) of mesothelioma in 204 countries and territories from 1990 to 2019 were estimated using vital registration and cancer registry data. The relationship between sociodemographic index and agestandardized DALY rate was determined, and DALYs attributable to occupational exposure to asbestos were calculated. Results: In 2019, there were 34,511 (95% uncertainty interval [UI], 31,199 to 37,771) incident cases of mesothelioma globally, with an age-standardized rate of 0.43 per 100,000 persons (95% UI, 0.38 to 0.47), which decreased between 1990 and 2019 by -12.6% (95% UI, -21.8% to -2.3%). Mesothelioma was responsible for 29,251 (95% UI, 26,668 to 31,006) deaths in 2019, with an age-standardized rate of 0.36 deaths per 100,000 persons (95% UI, 0.33 to 0.39), which decreased between 1990 and 2019 by -9.6% (95% UI, -17.8% to 21.1%). The age-standardized incidence rate increased in central Europe between 1990 and 2019 by 46.1% (95% UI, 16.6% to 72.4%). The Netherlands, Australia, and the United Kingdom had the highest agestandardized incidence rates. Incidence rates were higher in men than in women ages 45-49 to 90-94 years, peaking at 85-89 years. Occupational exposure to asbestos contributed to 85.2% (95% UI, 82.1% to 88.1%) of DALYs. Conclusions: The global burden of mesothelioma is decreasing in terms of age-standardized incidence and mortality rates. Mesothelioma remains a substantial public health challenge in many parts of the world.
引用
收藏
页码:976 / 983
页数:8
相关论文
共 50 条
  • [11] GLOBAL, REGIONAL, AND NATIONAL BURDEN OF LOW BACK PAIN, 1990-2019: A SYSTEMATIC ANALYSIS FOR THE GLOBAL BURDEN OF DISEASE STUDY 2019
    Wu, D.
    Wu, X.
    Wu, J.
    Tam, L. S.
    Gu, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 873 - 874
  • [12] Global burden of gout in 1990-2019: A systematic analysis of the Global Burden of Disease study 2019
    Jeong, Yeon Jae
    Park, Seoyeon
    Yon, Dong Keon
    Lee, Seung Won
    Tizaoui, Kalthoum
    Koyanagi, Ai
    Jacob, Louis
    Kostev, Karel
    Dragioti, Elena
    Radua, Joaquim
    Stickley, Andrew
    Oh, Hans
    Shin, Jae Il
    Smith, Lee
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (04)
  • [13] Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
    Feigin, Valery L.
    Stark, Benjamin A.
    Johnson, Catherine Owens
    Roth, Gregory A.
    Bisignano, Catherine
    Abady, Gdiom Gebreheat
    Abbasifard, Mitra
    Abbasi-Kangevari, Mohsen
    Abd-Allah, Foad
    Abedi, Vida
    Abualhasan, Ahmed
    Abu-Rmeileh, Niveen Me
    Abushouk, Abdelrahman, I
    Adebayo, Oladimeji M.
    Agarwal, Gina
    Agasthi, Pradyumna
    Ahinkorah, Bright Opoku
    Ahmad, Sohail
    Ahmadi, Sepideh
    Salih, Yusra Ahmed
    Aji, Budi
    Akbarpour, Samaneh
    Akinyemi, Rufus Olusola
    Al Hamad, Hanadi
    Alahdab, Fares
    Alif, Sheikh Mohammad
    Alipour, Vahid
    Aljunid, Syed Mohamed
    Almustanyir, Sami
    Al-Raddadi, Rajaa M.
    Salman, Rustam Al-Shahi
    Alvis-Guzman, Nelson
    Ancuceanu, Robert
    Anderlini, Deanna
    Anderson, Jason A.
    Ansar, Adnan
    Antonazzo, Ippazio Cosimo
    Arabloo, Jalal
    Arnlov, Johan
    Artanti, Kurnia Dwi
    Aryan, Zahra
    Asgari, Samaneh
    Ashraf, Tahira
    Athar, Mohammad
    Atreya, Alok
    Ausloos, Marcel
    Baig, Atif Amin
    Baltatu, Ovidiu Constantin
    Banach, Maciej
    Barboza, Miguel A.
    LANCET NEUROLOGY, 2021, 20 (10): : 795 - 820
  • [14] Global, regional, and national burden of premenstrual syndrome, 1990-2019: an analysis based on the Global Burden of Disease Study 2019
    Liu, Xingyu
    Li, Ruyuan
    Wang, Shixuan
    Zhang, Jinjin
    HUMAN REPRODUCTION, 2024, 39 (06) : 1303 - 1315
  • [15] Global, regional, and national childhood cancer burden, 1990-2019: An analysis based on the Global Burden of Disease Study 2019
    Wu, Ying
    Deng, Yujiao
    Wei, Bajin
    Xiang, Dong
    Hu, Jingjing
    Zhao, Peng
    Lin, Shuai
    Zheng, Yi
    Yao, Jia
    Zhai, Zhen
    Wang, Shuqian
    Lou, Weiyang
    Yang, Si
    Zhang, Dai
    Lyu, Jun
    Dai, Zhijun
    JOURNAL OF ADVANCED RESEARCH, 2022, 40 : 233 - 247
  • [16] Global, regional, and national HIV/AIDS disease burden levels and trends in 1990-2019: A systematic analysis for the global burden of disease 2019 study
    Tian, Xuebin
    Chen, Jingjing
    Wang, Xi
    Xie, Yiwen
    Zhang, Xiaodi
    Han, Dating
    Fu, Haijing
    Yin, Wanpeng
    Wu, Nanping
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [17] Global, regional, and national burden of hypertensive heart disease during 1990-2019: an analysis of the global burden of disease study 2019
    Lu, Yunyan
    Lan, Tian
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [18] Global, regional and national burdens of occupational injuries, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
    Lai, Jianqiang
    Li, Xianmin
    Liu, Wei
    Liufu, Qian
    Zhong, Chengfan
    INJURY PREVENTION, 2024,
  • [19] The global, regional, and national burden of appendicitis in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019
    Guan, Linjing
    Liu, Zhen
    Pan, Guangdong
    Zhang, Bulin
    Wu, Yongrong
    Gan, Tao
    Ouyang, Guoqing
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [20] Global, regional and national burden of alopecia areata and its associated diseases, 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019
    Jang, Hyeokjoo
    Park, Seoyeon
    Kim, Min Seo
    Yon, Dong Keon
    Lee, Seung Won
    Koyanagi, Ai
    Kostev, Karel
    Shin, Jae Il
    Smith, Lee
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (06)